User profiles for Emily Higgs
Emily F HiggsUniversity of Chicago Verified email at uchicago.edu Cited by 710 |
[HTML][HTML] Pre-symptomatic detection of COVID-19 from smartwatch data
Consumer wearable devices that continuously measure vital signs have been used to monitor
the onset of infectious disease. Here, we show that data from consumer smartwatches can …
the onset of infectious disease. Here, we show that data from consumer smartwatches can …
STING pathway agonism as a cancer therapeutic
The fact that a subset of human cancers showed evidence for a spontaneous adaptive immune
response as reflected by the T cell‐inflamed tumor microenvironment phenotype led to …
response as reflected by the T cell‐inflamed tumor microenvironment phenotype led to …
[HTML][HTML] Real-time alerting system for COVID-19 and other stress events using wearable data
Early detection of infectious diseases is crucial for reducing transmission and facilitating
early intervention. In this study, we built a real-time smartwatch-based alerting system that …
early intervention. In this study, we built a real-time smartwatch-based alerting system that …
[HTML][HTML] Pembrolizumab plus ipilimumab following anti-PD-1/L1 failure in melanoma
PURPOSE Combination of antiprogrammed cell death protein-1 (PD-1) plus anti–cytotoxic T-cell
lymphocyte-4 (anti-CTLA-4) immunotherapy shows greater response rates (RRs) than …
lymphocyte-4 (anti-CTLA-4) immunotherapy shows greater response rates (RRs) than …
[HTML][HTML] Tumor heterogeneity and clonal cooperation influence the immune selection of IFN-γ-signaling mutant cancer cells
PD-1/PD-L1 blockade can promote robust tumor regression yet secondary resistance often
occurs as immune selective pressure drives outgrowth of resistant tumor clones. Here using …
occurs as immune selective pressure drives outgrowth of resistant tumor clones. Here using …
Mainstreaming cancer genetics: a model integrating germline BRCA testing into routine ovarian cancer clinics
…, E Dow, Y Antill, CD Wrede, O McNally, E Higgs… - Gynecologic …, 2017 - Elsevier
Objective Owing to the rapid increase in clinical need, we aimed to implement and review
the performance of a mainstreaming model of germline BRCA1/2 genetic testing in eligible …
the performance of a mainstreaming model of germline BRCA1/2 genetic testing in eligible …
[HTML][HTML] A scalable, secure, and interoperable platform for deep data-driven health management
…, B Rolnik, A Celli, O Dagan-Rosenfeld, E Higgs… - Nature …, 2021 - nature.com
The large amount of biomedical data derived from wearable sensors, electronic health
records, and molecular profiling (eg, genomics data) is rapidly transforming our healthcare …
records, and molecular profiling (eg, genomics data) is rapidly transforming our healthcare …
COVIDOSE: a phase II clinical trial of low‐dose tocilizumab in the treatment of noncritical COVID‐19 pneumonia
Interleukin‐6 (IL‐6)–mediated hyperinflammation may contribute to the mortality of coronavirus
disease 2019 (COVID‐19). The IL‐6 receptor–blocking monoclonal antibody tocilizumab …
disease 2019 (COVID‐19). The IL‐6 receptor–blocking monoclonal antibody tocilizumab …
[HTML][HTML] Immune cell and tumor cell-derived CXCL10 is indicative of immunotherapy response in metastatic melanoma
AT cell-inflamed tumor microenvironment is characterized by the accumulation and local
activation of CD8+ T cells and Bat3-lineage dendritic cells, which together are associated with …
activation of CD8+ T cells and Bat3-lineage dendritic cells, which together are associated with …
Early detection of COVID-19 using a smartwatch
Wearable devices digitally measuring vital signs have been used for monitoring health and
illness onset and have high potential for real-time monitoring and disease detection. As such …
illness onset and have high potential for real-time monitoring and disease detection. As such …